Targeting IgE in severe atopic dermatitis with a combination of immunoadsorption and omalizumab

Autor: Zink, Alexander, Gensbaur, Anna, Zirbs, Michael, Seifert, Florian, Suarez, Isabel Leon, Mourantchanian, Vagkan, Weidinger, Stephan, Mempel, Martin, Ring, Johannes, Ollert, Markus

Publikováno v: Acta Derm.-Venereol. 96, 72-76 (2016)
Zink, A, Gensbaur, A, Zirbs, M, Seifert, F, Suarez, I L, Mourantchanian, V, Weidinger, S, Mempel, M, Ring, J & Ollert, M 2015, ' Targeting IgE in Severe Atopic Dermatitis with a Combination of Immunoadsorption and Omalizumab ', Acta Dermatovenereologica, vol. 96, no. 1, pp. 72-76 . https://doi.org/10.2340/00015555-2165

Patients with atopic dermatitis (AD) tend to have greatly elevated levels of serum immunoglobulin E (IgE). However, the role of IgE in the pathogenesis of AD is debated. This investigator-initiated open-label pilot study evaluates an anti-IgE-treatme

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e7e430e064b4f826c9cbd11d723e66a9
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=47904